institute of virology (viro)

• Antonis AF, van der Most RG, Suezer Y, Stockhofe-Zurwieden N, Daus F, Sutter G, Schrijver RS: Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge. Vaccine 2007, 25/25: 4818-27.
• Bohne F, Protzer U: Adoptive T-cell therapy as a therapeutic option in chronic viral hepatitis. J. Viral Hepatit. 2007, 14/1: 45-50.
• Brave A, Gudmundsdotter L, Gasteiger G, Hallermalm K, Kastenmüller W, Rollman E, Boberg A, Engstrom G, Reiland S, Cosma A, Drexler I, Hinkula J, Wahren B, Erfle V: Immunization of mice with the nef gene from Human Immunodeficiency Virus type 1: Study of immunological memory and long-term toxicology. Infect Agent Cancer. 2007, 2: 14.
• Bruss V: Hepatitis B virus morphogenesis. World J Gastroenterol. 2007, 3: 65-73.
• Cornberg M, Manns M, Protzer U: Infektionserkrankungen der Leber. Virushepatitis. In: Mertes, Marre. Klinische Infektiologie. Urban & Schwarzenegger 2007.
• Cornberg M, Protzer U, Dollinger M, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns M: Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the german guidelines for the management of HBV infection. Z Gastroenterol. 2007, 45: 1281-328.
• Cornberg M, Protzer U, Dollinger M, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Schirmacher P, Fleig WE, Manns M: Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: Upgrade of the German Guideline. Z Gastroenterol. 2007, 45: 525-574.
• Cosma A, Nagaraj R, Staib C, Diemer C, Wopfner F, Schätzl H, Busch DH, Sutter G, Goebel FD, Erfle, V: Evaluation of modified vaccinia virus Ankara as an alternative vaccine against Smallpox in chronically HIV type 1-infected individuals undergoing HAART. AIDS Res Hum Retroviruses. 2007, 23/6: 782-793.
• El-Gogo S, Staib C, Lasarte JJ, Sutter G, Adler H: Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model. J Gene Med. 2007, 10: 177-186.
• El-Gogo S, Staib C, Meyr M, Erfle V, Sutter G, Adler H: Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model. Vaccine 2007, 25/20: 3934-45.
• Ertmer A, Huber V, Gilch S, Yoshimori T, Erfle V, Duyster J, Elsasser HP, Schätzl HM: The anticancer drug imatinib induces cellular autophagy. Leukemia 2007, 21/5: 936-42.
• Flockerzi A, Maydt J, Frank O, Ruggieri A, Maldener E, Seifarth W, Medstrand P, Lengauer T, Meyerhans A, Leib-Mösch C, Meese E, Mayer J: Expression pattern analysis of transcribed HERV sequences is complicated by ex vivo recombination. Retrovirology 2007, 4: 39.
• Gasteiger G, Kastenmüller W, Ljapoci R, Sutter G, Drexler I: Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus ankara vector vaccines. J Virol. 2007, 81/21: 11925-36.
• Gudima S, He Y, Meier A, Chang J, Chen R, Jarnik M, Nicolas E, Bruss V, Taylor J: Assembly of hepatitis delta virus: particle characterization, including the ability to infect primary human hepatocytes. J Virol. 2007, 81: 3608-3617.
• Gudima S, Meier A, Dunbrack R, Taylor J, Bruss V: Two potentially important elements of the hepatitis B virus large envelope protein are dispensable for the infectivity of hepatitis delta virus. J Virol. 2007, 81: 4343-44347.
• Jost S, Turelli P, Mangeat B, Protzer U, Trono D: Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons. J Virol. 2007, 81/19:10588-10596.
• Kastenmüller W, Gasteiger G, Gronau JH, Baier R, Ljapoci R, Busch DH, Drexler I: Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination. J Exp Med. 2007, 204/9: 2187-98.
• Kraus B, Wolff H, Heilmann J, Elstner EF: Influence of Hypericum perforatum extract and ist single compounds on amyloid-beta mediated toxicity in microglial cells. Life Sci. 2007, 23: 884-894.
• Protzer U, Seyfried S, Quasdorff M, Sass G, Svorcova M, Webb D, Bohne F, Hösel M, Schirmacher P, Tiegs G: Antiviral activity and hepatoprotection by heme oxygenase-1 in hepatitis B virus infection. Gastroenterology 2007, 133: 1156-65.
• Rollier CS, Paranhos-Baccala G, Verschoor EJ, Verstrepen BE, Drexhage JA, Fagrouch Z, Berland JL, Komurian-Pradel F, Duverger B, Himoudi N, Staib C, Meyr M, Whelan M, Whelan JA, Adams VC, Larrea E, Riezu JI, Lasarte JJ, Bartosch B, Cosset FL, Spaan WJ, Diepolder HM, Pape GR, Sutter G, Inchauspe G, Heeney JL: Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity. Hepatology 2007,45/3: 602-613.
• Rothenaigner I, Kramer S, Ziegler M, Wolff H, Kleinschmidt A, Brack-Werner R: Long-term HIV-1 infection of neural progenitor populations AIDS 2007, 21/17: 2271-81.
• Schlosser E, Otero C, Wuensch C, Kessler B, Edelmann M, Brunisholz R, Drexler I, Legler DF, Groettrup M: A novel cytosolic class I antigen-processing pathway for endoplasmic-reticulum-targeted proteins. EMBO Rep. 2007, 8/10: 945-51.
• Schmitz F, Heit A, Guggemoos S, Krug A, Mages J, Schiemann M, Adler H, Drexler I, Haas T, Lang R, Wagner H: Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-β production in myeloid dendritic cells.Eur J Immunol. 2007, 37/2: 315-327.
• Überla K, Rosenwirth B, Ten Haaft P, Heeney J, Sutter G, Erfle V:Therapeutic immunization with Modified Vaccinia Virus Ankara (MVA) vaccines in SIV-infected rhesus monkeys undergoing antiretroviral therapy. J Med Primatol. 2007, 36/1: 2-9.
• Wedemeyer H, Cornberg M, Protzer U, Berg T, Dollinger MM: German guidelines on diagnosis and therapy of hepatitis B. Dtsch Med Wochenschr. 2007, 132/34-35:1775-82.
• Zeilfelder U, Frank O, Sparacio S, Schön U, Bosch V, Seifarth W, Leib-Mösch C: The potential of retroviral vectors to cotransfer endogenous retroviruses (HERVs) from human packaging cell lines. Gene 2007, 390: 175– 79.